SALT LAKE CITY, June 25, 2019 –Innovasis, Inc. an integrated research, development and manufacturing spinal device company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its LxHA™ Lateral Interbody Fusion Device. The LxHA™ lateral interbody is comprised of PEEK OPTIMA® HA Enhanced*, providing osteoconductive properties that may improve fusion**. …